141 related articles for article (PubMed ID: 8804264)
1. Harm-reduction strategies weapon of choice in BC's battle with drug addiction.
Kent H
CMAJ; 1996 Sep; 155(5):571-3. PubMed ID: 8804264
[TBL] [Abstract][Full Text] [Related]
2. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
Drucker E; Lurie P; Wodak A; Alcabes P
AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006
[No Abstract] [Full Text] [Related]
3. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
4. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
Razali SM
Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
[TBL] [Abstract][Full Text] [Related]
5. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
7. Malaysia and harm reduction: the challenges and responses.
Reid G; Kamarulzaman A; Sran SK
Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
[TBL] [Abstract][Full Text] [Related]
8. Opiate overdose deaths in the District of Columbia. II. Methadone-related fatalities.
Greene MH; Luke JL; DuPont RL
J Forensic Sci; 1974 Jul; 19(3):575-84. PubMed ID: 4604856
[No Abstract] [Full Text] [Related]
9. Harm minimization strategies: opinions of health professionals in rural and remote Australia.
Peterson GM; Northeast S; Jackson SL; Fitzmaurice KD
J Clin Pharm Ther; 2007 Oct; 32(5):497-504. PubMed ID: 17875117
[TBL] [Abstract][Full Text] [Related]
10. Rapid scale up of harm reduction in China.
Sullivan SG; Wu Z
Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
[TBL] [Abstract][Full Text] [Related]
11. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
Avants SK; Margolin A; Usubiaga MH; Doebrick C
J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
[TBL] [Abstract][Full Text] [Related]
12. [Forensic medicine experiences with methadone substitution in the Geneva canton].
La Harpe R; Perret G; Deglon JJ
Arch Kriminol; 2000; 206(1-2):1-7. PubMed ID: 11006820
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with client-reported HIV infection among clients entering methadone treatment.
MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
[TBL] [Abstract][Full Text] [Related]
14. Frequent needle exchange use and HIV incidence in Vancouver, Canada.
Wood E; Lloyd-Smith E; Li K; Strathdee SA; Small W; Tyndall MW; Montaner JS; Kerr T
Am J Med; 2007 Feb; 120(2):172-9. PubMed ID: 17275459
[TBL] [Abstract][Full Text] [Related]
15. Methadone in provincial prisons in British Columbia.
Rothon DA
Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):27-31. PubMed ID: 11365288
[TBL] [Abstract][Full Text] [Related]
16. NJ offers everything but needle exchange.
AIDS Alert; 1999 Jun; 14(6):63. PubMed ID: 11366408
[TBL] [Abstract][Full Text] [Related]
17. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users.
Termorshuizen F; Krol A; Prins M; Geskus R; van den Brink W; van Ameijden EJ
Drug Alcohol Depend; 2005 Aug; 79(2):231-40. PubMed ID: 16002032
[TBL] [Abstract][Full Text] [Related]
18. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
19. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
20. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
